VLNT for Lymphedema: Vascularized Lymph Node Transfer Explained

Some lymphedematous limbs can be helped by rerouting fluid around a blockage — that is the logic of LVA surgery. But what happens when the lymphatic vessels themselves have deteriorated so far that there is nothing left to reroute? For decades the answer was "nothing but compression." Today the answer is VLNT — Vascularized Lymph Node Transfer: a microsurgical operation that transplants living, functioning lymph nodes into the affected limb and, remarkably, persuades the body to grow new lymphatic channels around them.

This article explains the science behind VLNT, how the operation is performed, where donor nodes come from, what recovery involves, and the results patients can expect — as practised at PeriFORMÉ Centre, Pune by Dr. Pranav Thusay.

Why Transplant Lymph Nodes?

Lymph nodes are not passive filters. Each node is a compact, highly vascular organ that actively absorbs lymphatic fluid and passes it into the venous system — a built-in lymphovenous shunt. Nodes also secrete signalling molecules, most importantly VEGF-C (vascular endothelial growth factor C), the master switch for lymphangiogenesis — the growth of new lymphatic vessels.

When a cluster of healthy nodes is transplanted into a lymphedematous region with its blood supply intact, both mechanisms go to work:

• The pump effect: the living nodes begin absorbing excess tissue fluid and draining it into the veins they are connected to — an immediate, physiological drain placed exactly where it is needed.
• The regeneration effect: over the following months, VEGF-C released by the transplanted tissue stimulates surrounding lymphatics to sprout and reconnect, gradually rebuilding drainage pathways the disease had destroyed.

The phrase "with its blood supply intact" is the heart of the matter. Simply moving nodes would kill them; they must be transferred as a free flap — harvested with their feeding artery and vein, then reconnected to blood vessels at the recipient site under an operating microscope. This is why VLNT belongs firmly in the territory of experienced reconstructive microsurgeons.

Where Do the Donor Nodes Come From?

Several donor sites are in established use, and choosing between them is a key part of surgical planning:

The groin (superficial inguinal nodes)

The classic donor site — a well-hidden scar and reliable anatomy. Only carefully selected superficial nodes are taken, using reverse lymphatic mapping to leave the limb's own drainage untouched.

The neck (supraclavicular nodes)

A rich supply of nodes with a low risk of causing donor-site lymphedema, since the head and neck have abundant alternative drainage. The scar sits in a natural skin crease.

The omentum (inside the abdomen)

The omentum — a lymphatic-rich apron of tissue in the abdomen — can be harvested laparoscopically and carries essentially zero risk of donor-site lymphedema, because it is not responsible for draining any limb. It has become a preferred option in many modern practices, especially for larger or bilateral disease.

How the Operation Unfolds

1. Planning: ICG lymphography and clinical staging confirm that VLNT (rather than LVA alone) is the right operation. The recipient site — wrist or forearm for arm lymphedema, ankle or calf for leg lymphedema, or the axilla/groin where scar tissue is released — is chosen based on where fluid accumulates most.
2. Harvest: the donor node cluster is raised on its artery and vein — a flap often only a few centimetres across.
3. Scar release (when relevant): in post-cancer patients, constricting scar tissue in the axilla or groin is released, removing a mechanical stranglehold on residual lymphatics.
4. Microvascular transfer: the flap's vessels — typically 1–3 mm in diameter — are joined to recipient vessels under the microscope, restoring blood flow within minutes.
5. Closure and monitoring: the flap is inset and monitored closely for 2–5 days in hospital, standard practice for any free-flap procedure.

Total operating time is typically 3–6 hours. When VLNT is combined with other procedures — LVA at the same sitting, or autologous breast reconstruction using a DIEP flap that carries lymph nodes with it — timings extend accordingly.

Recovery: What Patients Actually Experience

• Hospital stay: 2–5 days, mostly for routine flap monitoring rather than because patients feel unwell.
• Downtime: light activity within 1–2 weeks; most patients return to work in 2–4 weeks depending on their job.
• Compression: continued through the recovery phase and tapered according to response — VLNT complements rather than instantly replaces CDT.
• The timeline of benefit: this is the most important expectation to set. Some patients notice early softening within weeks (the pump effect), but the full result matures over 12–18 months as lymphangiogenesis proceeds. VLNT is an investment procedure — the limb at one year is not the limb at one month.

Who Benefits Most from VLNT?

• Stage II–III lymphedema where ICG imaging shows few or no functioning lymphatic channels — the limbs LVA cannot help;
• Recurrent cellulitis — transplanted nodes restore local immune surveillance, and infection rates fall markedly in published series;
• Post-mastectomy patients planning breast reconstruction — nodes can be incorporated into the reconstruction, addressing the breast and the arm in one operation;
• Patients with axillary or inguinal scarring after surgery and radiotherapy, where scar release plus fresh vascularised tissue tackles the root cause.

Patients whose excess limb volume is predominantly fat and fibrosis may need staged debulking in addition — one more reason to be treated at a centre offering the complete range of lymphedema procedures.

Results: The Evidence Picture

Across international published series, well-selected VLNT patients consistently show meaningful limb-volume reduction, a substantial drop in cellulitis episodes — many series report infection rates falling by more than half — reduced heaviness and tightness, and improved quality-of-life scores. Combined approaches (VLNT plus LVA, or VLNT plus staged debulking) push results further in advanced disease. What determines success more than anything else is patient selection and microsurgical quality — the same operation performed on the wrong limb, or with compromised flap perfusion, delivers little.

Risks — and How an Experienced Team Manages Them

Honest counselling about VLNT includes its risks, because they are real and manageable rather than trivial or catastrophic:

• Flap-related risks. As with any free flap, the transferred tissue depends on its microvascular connections. In experienced hands, free-flap success rates exceed 95–98%; close monitoring in the first days allows any circulation problem to be corrected immediately.
• Donor-site lymphedema. The most discussed risk — taking nodes from a site that needed them. It is minimised by choosing low-risk donor sites (omentum and supraclavicular nodes carry the lowest risk) and by mapping techniques that identify which groin nodes drain the leg so they are left untouched.
• General surgical risks. Infection, seroma and scarring — uncommon and usually minor.
• The biological variable. The regenerative response differs between patients; some limbs improve dramatically, others modestly. Staging, imaging and honest patient selection keep expectations aligned with biology.

Common Questions About VLNT

Will I lose immunity by donating lymph nodes?

No. The body has hundreds of lymph nodes; transferring a small, carefully selected cluster does not measurably affect immune function. The relevant question is regional drainage, which is what donor-site mapping protects.

Can VLNT and LVA be done together?

Yes — combined physiological surgery is increasingly common in appropriately selected limbs: LVA drains what current channels allow, while VLNT rebuilds capacity for the long term. Your imaging determines whether a combined approach adds value.

How do I know whether I need VLNT or LVA?

You don't have to know — your imaging does. As a rule of thumb, limbs with functioning lymphatic channels on ICG lymphography are LVA candidates, while limbs showing mainly dermal backflow with few usable channels, or a history of extensive node dissection and radiation, point toward VLNT. Many patients are best served by a staged or combined plan, which is exactly the judgement a dedicated lymphedema consultation provides.

Is VLNT suitable for filariasis-related lymphedema?

Selected patients benefit, provided active infection is fully treated first and the limb is staged accurately. Filarial lymphedema is common in India, and treatment plans at PeriFORMÉ routinely account for it.

Why Have VLNT Done at PeriFORMÉ, Pune

VLNT is free-flap surgery, and free-flap surgery is unforgiving of inexperience. Dr. Pranav Thusay is Pune's only dedicated lymphedema surgeon, with M.Ch training in Plastic & Reconstructive Surgery, fellowship training in microsurgery in Bern, Switzerland, further breast reconstructive fellowship training in Brussels, Belgium, and over 1,000 microsurgical reconstructions. Just as importantly, PeriFORMÉ offers LVA, VLNT, debulking and full CDT under one roof — so the operation you are offered is the one your imaging says you need.

If you have been told your lymphedema is "too advanced for surgery," VLNT may be exactly the procedure that was missing from that conversation. Book a consultation at our Baner or Sasoon Road clinic, or start with our complete guide to lymphedema treatment options in Pune.